GlassScriptPhysician profile
Modupe Agunbiade
NPI 1528443033
$5,909.38
in general payments reported to CMS, 2019-2025
32 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,030 · 2020: $283 · 2021: $605 · 2022: $633 · 2023: $819 · 2024: $1,257 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,358.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,162.00 | 2019 | |
| Prodigy Surgical Distribution, INC. | $868.28 | 2019 | |
| Cardiovascular Systems INC. | $691.78 | 2020-2023 | Diamondback Peripheral |
| Paratek Pharmaceuticals, INC. | $420.57 | 2021-2025 | Nuzyra |
| Kerecis Limited | $377.65 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Stryker Corporation | $272.20 | 2022-2024 | Anchorage, Ortholoc 2 Lapifuse, Augment Injectable |
| Smith+Nephew, INC. | $253.82 | 2021-2024 | Collagenase Santyl, Regranex |
| Inari Medical, INC. | $210.33 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Limflow System |
| Paragon 28, INC. | $169.55 | 2021-2024 | Phantom Hindfoot |
| Nabriva Therapeutics, Plc | $149.84 | 2021-2022 | |
| Next Science LLC | $147.34 | 2023 | Xperience, Blastx, Surgx |
| Integra Lifesciences Corporation | $135.99 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sandoz INC. | $135.45 | 2020-2021 | |
| Advanced Oxygen Therapy INC. | $134.12 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Cagent Vascular INC | $125.00 | 2024 | Serrantor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $102.30 | 2022-2025 | |
| Organogenesis INC. | $75.04 | 2024-2025 | Affinity, Apligraf |
| Alfasigma USA, INC. | $55.96 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.72 | 2020-2022 | |
| Kci USA, INC. | $43.06 | 2021-2023 | Activ.A.C. |
| Convatec INC. | $42.04 | 2023-2024 | |
| Resmed Corp | $41.80 | 2022 | |
| Sebela Pharmaceuticals INC. | $41.06 | 2020-2021 | |
| Polynovo North America LLC | $37.56 | 2023 | |
| Solventum Corporation | $26.70 | 2025 | Activ.A.C. |
| Orthofix Medical, INC. | $22.36 | 2024 | Physio-Stim |
| Urgo Medical North America, LLC | $21.93 | 2024 | Urgok2 |
| Musculoskeletal Transplant Foundation INC. | $20.62 | 2023-2025 | |
| Abbott Laboratories | $19.84 | 2024 | Proclaim |
| Averitas Pharma INC. | $18.49 | 2024 | Qutenza |
| Acera Surgical, INC. | $17.83 | 2023 | Restrata Wound Matrix |
| Kowa Pharmaceuticals America, INC. | $13.15 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Modupe Agunbiade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.